- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-1/CTLA-4 Bispecific
Total 58760 results
-
Merck Sharp & Dohme LLCCompleted
-
University of CopenhagenHvidovre University Hospital; Aga Khan University; VU University of Amsterdam; Comprehensive...RecruitingCesarean Section Complications | Stillbirth | Delivery Complication | Delivery Delayed | Apgar; 0-3 at 1 Minute | Apgar; 4-7 at 1 MinuteTanzania
-
Merck Sharp & Dohme LLCCompleted
-
Cancer Hospital of Guangxi Medical UniversityRecruitingNasopharyngeal Carcinoma | SintilimabChina
-
Immunocore LtdAstraZenecaCompletedMalignant MelanomaUnited States
-
Xuhua DuanRecruiting
-
Genentech, Inc.Completed
-
National Cancer Institute (NCI)Not yet recruitingMetastatic Melanoma | Locally Advanced Melanoma | Metastatic Alveolar Soft Part Sarcoma | Metastatic Non Small Cell Lung Cancer | Metastatic Hepatocellular Carcinoma | Locally Advanced Hepatocellular Carcinoma | Metastatic Small Cell Lung Cancer | Locally Advanced Non Small Cell Lung Cancer | Locally... and other conditionsUnited States
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingHepatocellular CarcinomaChina
-
University Hospital, BordeauxRecruitingMetastatic Renal Cell Carcinoma | Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC ScoreFrance
-
University Hospital HeidelbergDepartment of Dermatology, Heidelberg University HospitalCompletedMelanoma | Exercise | PD-1 AntibodiesGermany
-
San Francisco Veterans Affairs Medical CenterMerck Sharp & Dohme LLCUnknown
-
Merck Sharp & Dohme LLCRecruitingSmall Cell Lung CancerUnited States, Australia, Belgium, Bulgaria, Canada, China, France, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Portugal, Romania, Russian Federation, Serbia, South Africa, Spain, Turkey, Ukraine, United... and more
-
NYU Langone HealthMerck Sharp & Dohme LLCTerminatedSmall Cell Lung Cancer (SCLC)United States
-
Vifor Fresenius Medical Care Renal PharmaTigermed Consulting Co., LtdCompletedEnd Stage Renal Disease on HemodialysisChina
-
Merck Sharp & Dohme LLCEisai Inc.CompletedNon-small Cell Lung CancerChina, Israel, United States, Australia, Canada, Colombia, Estonia, France, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Poland, Russian Federation, Taiwan, Turkey, Ukraine
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Australia, Canada, Chile, China, France, Greece, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Sweden
-
Merck Sharp & Dohme LLCEisai Inc.CompletedAdvanced MelanomaCanada, United States, Australia, Spain, Sweden
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Chile, China, France, Germany, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell LungIndia
-
Rapa Therapeutics LLCRecruitingBreast Cancer | Head and Neck Cancer | Gastric Cancer | Solid Tumor | Bladder Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Malignant Melanoma | Carcinoma of Unknown Primary | Squamous Cell Carcinoma of Larynx | Squamous Cell Carcinoma of Oral Cavity | Squamous Cell Carcinoma of Nasopharynx and other conditionsUnited States
-
UCB Japan Co. Ltd.CompletedEpilepsy | Partial-onset SeizuresJapan
-
Merck Sharp & Dohme LLCCompleted
-
Sun Yat-sen UniversityRecruitingEsophageal Squamous Cell Carcinoma | Oligometastatic DiseaseChina
-
Shanghai Zhongshan HospitalRecruitingHepatocellular CarcinomaChina
-
Pyrotech Therapeutics, Inc.RecruitingLocally Advanced or Metastatic Solid TumorsUnited States
-
Peking University First HospitalYiZhou International Cancer HospitalUnknownImmunotherapy | Proton Therapy
-
Merck Sharp & Dohme LLCRecruitingEsophageal Squamous Cell CarcinomaJapan, Korea, Republic of, Taiwan, China, Italy, Switzerland, Brazil, Germany, Singapore, Turkey, Thailand, Chile, Norway
-
Merck Sharp & Dohme LLCActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC)Japan, Italy, Brazil, Chile, France, Germany, Korea, Republic of, Norway, Singapore, Switzerland, Taiwan, Thailand, Turkey
-
Merck Sharp & Dohme LLCActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Brazil, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, United Kingdom
-
Icahn School of Medicine at Mount SinaiCrohn's and Colitis FoundationActive, not recruitingUlcerative Colitis (Disorder)United States
-
Diwakar DavarMerck Sharp & Dohme LLCActive, not recruitingSquamous Cell CarcinomaUnited States
-
The Affiliated Hospital of Qingdao UniversityUnknown
-
Hunan Cancer HospitalCompleted
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu vcare pharmaceutical technology co., LTDCompletedHealthy Subjects | PK/PDChina
-
RenJi HospitalRecruitingUrothelial Carcinoma Bladder | PD-1 InhibitorChina
-
Merck Sharp & Dohme LLCCompletedMerkel Cell CarcinomaUnited States, Australia, Canada, France, Italy, New Zealand, Spain, Sweden
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CancerPoland, Russian Federation, United States, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Chinese PLA General HospitalLinkDoc Technology (Beijing) Co. Ltd.UnknownAdvanced Solid TumorsChina
-
Medical University of SilesiaMaria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,...RecruitingNewly Diagnosed GlioblastomaPoland
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRenal Cell CarcinomaPoland, Australia, United States, Canada, France, Hungary, Ireland, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Xuanwu Hospital, BeijingUnknownNon-small Cell Lung Cancer | PD-1 Antibody | Lung Cancer Stage II
-
Changzhou No.2 People's HospitalNot yet recruitingAdvanced Solid Tumor
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Peking UniversityRecruitingHepatocellular Carcinoma | Portal Vein ThrombosisChina